
Dr. Adel Chaouch, Marathon Oil’s Director of Corporate Social Responsibility, is also the first Director of the Board for the Corporate Alliance on Malaria in Africa (CAMA). Dr. Chaouch discusses how CAMA is poised to play a significant role in improving the effectiveness of malaria-control programs in the region.
CAMA organizing private sector collaboration with PMI, Global Fund and other global initiatives Creating a framework to increase the impact of malaria interventions in local communities Malaria fight enhanced through targeted private sector involvement
Coalition and CAMA members are collaborating to draft a management roadmap for malaria action to better guide the coordination and integration of private sector malaria programs.
The Coalition recently convened high-level leadership from Chevron Corporation, Halliburton, Marathon Oil, Pfizer Inc., Sumitomo and Syngenta, along with the President’s Malaria initiative to review and fine tune the draft roadmap.
The finished guide will provide direction for private sector collective action on malaria as part of a broader effort to meet the Millennium Development Goal of reducing malaria deaths by 50 percent by 2010.
Representatives from The Coalition are now soliciting feedback from external partners and stakeholders prior to the finalization of the roadmap.
CAMA’s founding member companies—many of whom already implement or finance leading-edge malaria initiatives—are Marathon Oil Corporation, Bayer Environmental Science, Global Industries, Cameron International, Coca Cola Africa, Chevron, EDG Engineers, Halliburton, Noble Energy, Wood Group and WorleyParsons. Each company has committed to the CAMA ’s goals and objectives and will play an active role in accomplishing CAMA's mandate.
“Malaria is one of the greatest threats to global health and economic welfare, but a well-organized corporate response can make a tremendous difference. CAMA’s members will create a framework around which companies can implement the current and best practices in malaria interventions,” said Dr. Adel Chaouch, Director of the CAMA Board and Director of CSR for Marathon Oil. “We are creating a forum where companies can gather to cooperate at the corporate level, and also within specific countries, so they can work more efficiently with governments to the benefit of hard-hit local communities.”
“For businesses that operate in malaria-endemic parts of Africa, there’s a huge business case to reduce malaria incidence, and companies have mounted some amazing malaria control initiatives,” said Pamela Bolton, GBC Associate Vice President of Knowledge, Evaluation and Performance. “By collaborating with national governments and civil society players such as local NGOs, the private sector can not only broaden the reach of these malaria interventions, but also increase their cost-effectiveness and bring a higher return on investment.”